Addressing risk factors, screening, and preventative treatment for diabetic retinopathy in developing countries: a review
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
The number of people with diabetic retinopathy (DR) has increased with the increasing prevalence of diabetes mellitus worldwide, especially in developing countries. In recent years, the successful implementation of public health programs in developed countries has been thought to contribute to decreases in blindness from DR. Developing countries, however, have not seen the same improvements, and their public health interventions still face significant challenges. In this review we describe the current state of public health approaches including risk factor control, screening and treatment techniques for DR in developing countries, and suggest recommendations. While the awareness of DR is variable, specific knowledge about DR is low, such that many patients have already experienced vision loss by the time they are screened. Attempts to improve rates of screening, in particular through non‐mydriatic cameras and tele‐screening, are ongoing and promising, although challenges include collaboration with healthcare systems and technology failures. Laser treatment is the most readily available, with anti‐VEGF therapy and vitreo‐retinal surgery increasingly sought after and provided. Recommendations include the use of ‘targeted mydriasis’ for fundus imaging to address high rates of ungradable images, increased communication with diabetes management services to improve patient retention and mobilization of access to DR treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global prevalence and major risk factors of diabetic retinopathy
Yau, J. W. Y., Rogers, S. L., Kawasaki, R., Lamoureux, E. L., Kowalski, J. W., Bek, T., Chen, S.-J., Dekker, J. M., Fletcher, A., Grauslund, J., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1909 · Cited by 4,985 · cited 3×
“6% among people with diabetes globally.(2,4,5) Several landmark studies, including the Early Treatment Diabetic Retinopathy Study (ETDRS), have shown that blindness from DR is almost entirely preventable given early detection, treatment and effective diabetes control.”
BackgroundSelf-citationGlobal nutrition transition and the pandemic of obesity in developing countries
Popkin, B. M., Adair, L. S., & Ng, S. W. (2012) · Nutrition Reviews · doi:10.1111/j.1753-4887.2011.00456.x · Cited by 4,313
Cheung, N., Mitchell, P., & Wong, T. Y. (2010) · The Lancet · doi:10.1016/s0140-6736(09)62124-3 · Cited by 3,288
(2) Classification and diagnosis of diabetes
American Diabetes Association (2015) · Diabetes Care · doi:10.2337/dc15-s005 · Cited by 1,841
Resnikoff, S., Felch, W., Gauthier, T.-M., & Spivey, B. (2012) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2011-301378 · Cited by 405
Prevalence of diabetic retinopathy in type 2 diabetes in developing and developed countries
Ruta, L. M., Magliano, D. J., LeMesurier, R., Taylor, H. R., Zimmet, P. Z., & Shaw, J. E. (2013) · Diabetic Medicine · doi:10.1111/dme.12119 · Cited by 311
Diabetic retinopathy management guidelines
Chakrabarti, R., Harper, C. A., & Keeffe, J. E. (2012) · Expert Review of Ophthalmology · doi:10.1586/eop.12.52 · Cited by 112 · cited 1×
“found that only 6 of 32 sets of guidelines identified by literature and internet search were published in developing countries.(58) Although this discrepancy may come from barriers to international accessing of existing national guidelines, it also suggests difficulty in implementing guidelines in resource and infrast…”
BackgroundKhan, T., Bertram, M. Y., Jina, R., Mash, B., Levitt, N., & Hofman, K. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.05.006 · Cited by 74 · cited 2×
“examined another program screening 14541 patients in Cape Town, South Africa.(77) They found the incremental cost-effectiveness ratio to be US $1206 per blindness case averted, which was costeffective; this assumed, however, all laser treatments to be prevented cases of blindness, and also included identification and…”
BackgroundRani, P. K., Raman, R., Sharma, V., Mahuli, S. V., Tarigopala, A., Sudhir, R. R., Kumaramanickavel, G., & Sharma, T. (2007) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.120659 · Cited by 51
Thapa, R., Joshi, D. M., Rizyal, A., Maharjan, N., & Joshi, R. D. (2014) · Nepalese Journal of Ophthalmology · doi:10.3126/nepjoph.v6i1.10760 · Cited by 48
Cited by
Porwal, P., Pachade, S., Kamble, R., Kokare, M., Deshmukh, G., Sahasrabuddhe, V., & Meriaudeau, F. (2018) · Data · doi:10.3390/data3030025 · Cited by 923
IDRiD: Diabetic Retinopathy – Segmentation and Grading Challenge
Porwal, P., Pachade, S., Kokare, M., Deshmukh, G., Son, J., Bae, W., Liu, L., Wang, J., Liu, X., Gao, L., et al. (2020) · Medical Image Analysis · doi:10.1016/j.media.2019.101561 · Cited by 372
Diabetes in developing countries
Misra, A., Gopalan, H., Jayawardena, R., Hills, A. P., Soares, M., Reza‐Albarrán, A. A., & Ramaiya, K. L. (2019) · Journal of Diabetes · doi:10.1111/1753-0407.12913 · Cited by 300
Ipp, E., Liljenquist, D., Bode, B., Shah, V. N., Silverstein, S., Regillo, C. D., Lim, J. I., Sadda, S., Domalpally, A., Gray, G., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.34254 · Cited by 256
The War on Diabetic Retinopathy: Where Are We Now?
Wong, T. Y., & Sabanayagam, C. (2019) · Asia-Pacific Journal of Ophthalmology · doi:10.1097/apo.0000000000000267 · Cited by 84
“In India, it has been shown that nearly half of the people with diabetes visit ophthalmologists only after their vision is lost.(37) In China, 67% of patients with diabetes who attended a specialist eye clinic for the first time were found to have VTDR.”
BackgroundSelf-citation
Metadata
- Authors
- Lin, S., Ramulu, P., Lamoureux, E. L., & Sabanayagam, C.
- Venue
- Clinical & Experimental Ophthalmology
- Publisher
- Wiley
- Published
- 2016-05
- Volume
- 44
- Issue
- 4
- Pages
- 300-320
- ISSN
- 1442-6404 (ISSN-L)
- 1442-9071
- OpenAlex
- W2297996442
- Cited by
- 54
- References
- 10
- FWCI
- 5.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.